2019
- Vorobiev, A. Evaluation of the safety and efficacy of АI for detection of chronic non-communicable diseases in remote areas / Vorobiev A., Vorobiev P., Krasnova L., Holownia-Voloskova M., Oparin I. // Value in health ISPOR Europe 2019 November 2-6, 2019
- Tolkushin, A. Testing of a Questionnaire for Assessment of Relative Weights of Medicines Value Criteria / Tolkushin A., Davydovskaya M., Pogudina N., Ermolaeva T. // Value in health ISPOR Europe 2019 November 2-6, 2019, Copengagen, Denmark.
- Tolkushin, A. How to Deal with Contradictory Cost-Effectiveness of Therapeutically Similar Medicines? / Tolkushin A., Ermolaeva T., Davydovskaya M. // Value in health ISPOR Europe 2019 November 2-6, 2019, Copengagen, Denmark.
- Shmidt, E. Use of tofacitinib (TOFA) in patients with rheumatoid arthritis (RA) in Moscow: analysis data from Moscow Unified Arthritis Registry (MUAR) / Shmidt E., Koltsova E., Lukina G., Lytkina K., Zhilyaev E. // International journal of rheumatic di
- Shmidt, E. The results of the use of Tofacitinib (TOFA) in patients with rheumatoid arthritis (ra) in Moscow. analysis data from Moscow unified arthritis registry(Muar) / Shmidt E., Koltsova E., Lukina G., Lytkina K., Zhilyaev E. // Annals of the rheuma
- Poliakova, K. Cost Structure Analysis: Drug Therapy of Patients with Stomach Cancer in Moscow. Analysis of Patient Detection / Poliakova K., Fisun A., Ermolaeva T. // Value in health ISPOR Europe 2019 November 2-6, 2019, Copengagen, Denmark.
- Pinchuk, A.V. Successful kidney transplantation from a deceased donor to a recipient withchronic intradialytic hypotension (clinical case report) / Pinchuk A.V., Zhuravel N.S., Balkarov A.G., Kondrashkin A.S. // Transplantation Reports.
- Pinchuk, A.V. Pancreas transplantation with isolated splenic artery blood supply – Single center experience / Pinchuk A.V., Dmitriev Y.A., Anisimov R.V., Storozhev A.G., Balkarov A.S., Kondrashkina I.V., Khodilinab R.S. // Asian Journal of Surgery.
- Lytkina, K. Persistence of biologies in teatment of psoriatis arthritis patients - the first data from Moscow unified register of arthritis (MUAR) / Lytkina K., Lukina G., Schmidt E., Koltsova E., Zhilyaev E. // International journal of rheumatic disea
- Lvtkina, K. The survival of biologics in psoriatic arthritis - the first data from Moscow unified register of arthritis (Muar) / Lvtkina K., Shmidt E., Lukina G., Koltsova E., Zhilyaev E. // Annals of the rheumatic diseases.
- Krysanova, V. The Comparative Pharmacoeconomic Analysis of Using Different Drugs for First-Line Therapy of Metastatic Renal Cell Carcinoma in Russia / Krysanova V., Krysanov I., Ermakova V. // Value in health ISPOR Europe 2019 November 2-6, 2019, Copeng
- Krysanova, V. Comparative Pharmacoeconomic Analysis of Using Different Target Drugs for Second-Line Therapy of Metastatic Renal Cell Carcinoma in Russia / Krysanova V., Krysanov I., Ermakova V. // Value in health ISPOR Europe 2019 November 2-6, 2019, Co
- Kornilova, E. The Economic Reason for the Use of Vedolizumab Compared with Inhibitors of Tnf-α in Patients with Inflammatory Bowel Disease on the Example of Moscow / Kornilova E., Poliakova K., Ermolaeva T., Davydovskaya M., Ermolaeva A., Fisun A. // V
- Koltsova, E. Switching from etanercept in patients with rheumatoid arthritis. Data from Moscow Unified Arthritis Registry (MUAR) / Koltsova E., Lukina G., Shmidt E., Lytkina K., Zhilyaev E. // International journal of rheumatic diseases.
- Knyazev, O. Response Loss When Transferring Patients With Inflammatory Bowel Disease From the Original Drug Infliximab to Its Biosimilar / Knyazev O., Kagramanova A., Shkurko T., Lishchinskaya A., Kulakov D., Zvyaglova M., Parfenov A. // The american jo
- Knyazev, O. Frequency of response loss when transferring patients with inflammatory bowel disease from the original drug infliximab to its biosimilar / Knyazev O., Kagramanova A., Shkurko T. // Turkish journal of Gastroenterology.
- Klabukova, D. Efficacy and Safety of Abobotulinumtoxina in Adults with Upper Limb Spasticity after Stroke: a Systematic Review / Klabukova D., Krysanova V., Davydovskaya M., Ermolaeva T. // Value in health ISPOR Europe 2019 November 2-6, 2019, Copengag
- Holownia-Voloskova, M. Budget Impact Analysis of Inclusion in the Public Financing Ocrelizumab Therapy for Primary-Progredient and Highly Active Remitting Forms of Multiple Scelerosis in the Russian Federation / Holownia-Voloskova M., Davydovskaya M., E
- Fisun, A. Cost of Illness Analysis: Drug Therapy of Patients with a Malignant Neoplasms of Female Genital Organs in Moscow / Fisun A., Poliakova K., Ermolaeva T. // Value in health ISPOR Europe 2019 November 2-6, 2019, Copengagen, Denmark.
- Daneasa, D. Measuring the level of transparency with regard to how substance dependency is treated in the public health systems of some European and Neighbouring countries / Daneasa D., Subtirelu M., Baran A., Gaitova K., Holownia-Voloskova M., Csanádi